Alpha-2b interferon in the treatment of advanced chronic lymphocytic leukemia
Klener, P.; Háber, J.; Hausner, P.
Neoplasma 36(2): 215-220
1989
ISSN/ISBN: 0028-2685 PMID: 2716926 Document Number: 346354
In four patients treated for progressive B-CLL, stage C, with alpha-2b interferon a detailed analysis of the distribution of surface molecules characterizing both the leukemic and the residual populations of peripheral blood lymphocytes as evaluated by flow cytometry did not reveal any significant changes during and after the interferon therapy. With the dosage of 3 x 10(6) IU of interferon injected subcutaneously three times per week, no effect on progression of the disease was detected. The treatment was well tolerated, thrombocytopenia was the only side-effect observed.
Document emailed within 1 workday
Related Documents
Boussiotis, V.A.; Pangalis, G.A. 1988: Randomized clinical trial with alpha 2b-interferon in 26 stage a untreated B-chronic lymphocytic leukemia patients Nouvelle Revue Francaise d'Hematologie 30(5-6): 471-473Karray, S.; Delfraissy, J.F.; Merle-Beral, H.; Wallon, C.; Debre, P.; Galanaud, P. 1988: Positive effects of interferon-alpha on B cell-type chronic lymphocytic leukemia proliferative response Journal of Immunology 140(3): 774-778
Pozzato, G.; de Paoli, P.; Franzin, F.; Tulissi, P.; Moretti, M.; Basaglia, G.; Santini, G.F. 1994: Effects of alpha-interferon and steroids on CD23 expression and release in B-cell chronic lymphocytic leukemia Haematologica 79(3): 205-212
Morabito, F.; Callea, I.; Rodinò, A.; Messina, G.; Callea, V.; Iacopino, P.; Nobile, F.; Brugiatelli, M. 1995: Modulation of purine analogs- and chlorambucil-induced cytotoxicity by alpha-interferon and interleukin-2 in chronic lymphocytic leukemia Leukemia 9(9): 1450-1455
Russo, D.; Fanin, R.; Zuffa, E.; Damiani, D.; Gallizia, C.; Michieli, M.; Testoni, N.; Benfenati, D.; Visani, G.; Zaccaria, A. 1990: Sequential treatment of Ph-positive chronic myeloid leukemia with interferon gamma and interferon alpha Haematologica 75(4): 334-339
Piro, L.D. 1993: 2-Chlorodeoxyadenosine: treatment of hairy cell leukemia, chronic lymphocytic leukemia, and lymphocytic lymphoma Seminars in Hematology 30(4 Suppl 6: 28-30
Zuffa, E.; Bandini, G.; Bonini, A.; Santucci, M.A.; Martinelli, G.; Rosti, G.; Testoni, N.; Zaccaria, A.; Tura, S. 1998: Prior treatment with alpha-interferon does not adversely affect the outcome of allogeneic BMT in chronic phase chronic myeloid leukemia Haematologica 83(3): 231-236
Faber, E.; Jarosová, M.; Divoký, V.; Luhový, M.; Komenda, S.; Sulovská, I.; Hubácek, J.; Slezák, P.; Papajik, T.; Raida, L.; Heczko, M.; Indrák, K. 1997: Interferon-alpha in the treatment of patients with chronic myeloid leukemia Vnitrni Lekarstvi 43(1): 13-17
Hoki, T.; Kuroda, H.; Ishikawa, K.; Okagawa, Y.; Yamada, M.; Sakurai, T.; Fujii, S.; Maeda, M.; Fujita, M.; Nagashima, K.; Nojiri, S.-I.; Joumen, W.; Kato, J. 2012: Chronic hepatitis C presenting with hepatic involvement by chronic lymphocytic leukemia responding to polyethylene glycol interferon-α-2b Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(10): 1551-1554
Molnár, L.; Nagy, A.; Dávid, M.; Szomor, A.ád.; Méhes, G.áb.; Kovács, G.áb.; Losonczy, H. 2004: Results of imatinib therapy in late-stage chronic myeloid leukemia after treatment with interferon-alpha Orvosi Hetilap 145(17): 901-907
Casado, L.F.; Picó, M.; Gómez, C.; Ferro, M.T.; Fernández-Rañada, J.M.; Steegmann, J.L. 1997: Fluctuating molecular remission in patients with chronic myeloid leukemia with long term complete cytogenetic response after alpha interferon treatment Medicina Clinica 109(7): 251-255
Martino, R.; Brunet, S.; García, A.; Sureda, A.; Soler, J.; Martínez, C.; Domingo-Albós, A.; Baiget, M. 1995: Various patterns of chimerism after allogeneic bone marrow transplantation for advanced chronic lymphocytic leukemia Bone Marrow Transplantation 16(6): 783-786
Ostlund, L.; Einhorn, S.; Robèrt, K.H. 1986: Induction of 2',5'-oligoadenylate synthetase and blast transformation in primary chronic lymphocytic leukemia cells following exposure to interferon in vitro Cancer Research 46(4 Part 2): 2160-2163
Balan, V.; Nelson, D.R.; Sulkowski, M.S.; Everson, G.T.; Lambiase, L.R.; Wiesner, R.H.; Dickson, R.C.; Garcia, A.; Moore, P.A.; Yu, R.; Subramanian, G.M. 2006: Modulation of interferon-specific gene expression by albumin-interferon-alpha in interferon-alpha-experienced patients with chronic hepatitis C Antiviral Therapy 11(7): 901-908
Singer, M.K.; Assem, M.; Abdel Ghaffar, A.B.; Morcos, N.Y. 2011: Role of TNF-alpha as a survival prognostic marker in chronic lymphocytic leukemia patients Egyptian Journal of Immunology 18(1): 51-60
Meloni, G.; Russo, D.; Baccarani, M.; Testoni, N.; Martinelli, G.; Fanin, R.; Zuffa, E.; Rosti, G.; Alimena, G.; Saglio, G.; Mandelli, F.; Tura, S. 1999: A prospective study of alpha-interferon and autologous bone marrow transplantation in chronic myeloid leukemia. the Italian Co-operative Study Group on Chronic Myeloid Leukemia Haematologica 84(8): 707-715
Marie, J.P.; Simonin, G.; Legrand, O.; Delmer, A.; Faussat, A.M.; Lewis, A.D.; Sikic, B.I.; Zittoun, R. 1995: Glutathione-S-transferases pi, alpha, mu and mdr1 mRNA expression in normal lymphocytes and chronic lymphocytic leukemia Leukemia 9(10): 1742-1747
Ladoyanni, E.; Nambi, R. 2005: Psoriasis exacerbated by interferon-alpha in a patient with chronic myeloid leukemia Journal of Drugs in Dermatology: Jdd 4(2): 221-222
Ezaki, K. 2000: Interferon-alpha and cytosine arabinoside therapy in chronic myeloid leukemia Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(Suppl 2): 279-284
Uehara, E.; Uesugi, T.; Tasaka, T.; Matsuhashi, Y.; Tamura, T.; Kuwajima, M.; Nagai, M. 2002: Reversible cardiomyopathy secondary to interferon-alpha in chronic myelogenous leukemia Gan to Kagaku Ryoho. Cancer and ChemoTherapy 29(2): 317-321